MedPath

Prophylactic effect of clofibrate in very low birth weight neonates' hyperbilirubinemia

Phase 3
Conditions
Hyperbilirubinemia in low birth weight neonates.
Registration Number
IRCT138706311162N5
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
52
Inclusion Criteria

Inclusion:low birth weight neonates who were admitted to NICU of Emamreza Hospital.These neonates were healthy, breastfed with birth weight equal or less than 2500 grams.
exclusion: Babies with hemolysis, infections, congenital anomalies and metabolic diseases were excluded

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum Bilirubin. Timepoint: before intervention, 24, 48, 72, and 96 hours after intervention. Method of measurement: measurment of serum bilirubin (diazo method).
Secondary Outcome Measures
NameTimeMethod
Incidence of jaundice in low birth weight neonates. Timepoint: before intervention,24,48,72 and 96 hours after intervention. Method of measurement: Physical examination (yes/no).
© Copyright 2025. All Rights Reserved by MedPath